Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 10/20 | 0.70 |
| ▸ | PDE4B | Q07343 | 10/20 | 0.70 |
| ▸ | PDE4C | Q08493 | 10/20 | 0.70 |
| ▸ | PDE4D | Q08499 | 10/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11469342 | 0.99 | PDE4A (0.72) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL11462320 | 0.91 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL10815947 | 0.90 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL11477589 | 0.89 | ADORA2B (0.61) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL11458768 | 0.88 | PDE4A (0.63) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL11476753 | 0.88 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL8071813 | 0.87 | ADORA1 (0.76) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL10861746 | 0.87 | ADORA1 (0.76) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL10813433 | 0.86 | ADORA1 (0.74) | PDE4APDE4BPDE4CPDE4DADORA2B | |
| SCHEMBL9294503 | 0.85 | PDE4A (0.75) | PDE4APDE4BPDE4CPDE4DADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4207321-A | PROMOTES BLOOD PERFUSION | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-06-10 | — | — | US | disclosed |